Tracking cfDNA levels may help better evaluate surgery colorectal cancer effectiveness

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.”

Which Anticoagulant Is Safest for Afib Patients With Cirrhosis?

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a

July 9, 2024

Harvard study: Perceived time significantly impacts physical wound healing rate

Perceived time has a significant impact on the actual time it takes to heal physical wounds, according to new research by Harvard psychologists Peter Aungle

January 2, 2024

Current screening guidelines could miss prostate cancer in transgender women receiving estrogen

Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.